<DOC>
	<DOCNO>NCT03071198</DOCNO>
	<brief_summary>Clinical effect neoadjuvant hierarchical treatment base chemotherapy T3-4N0-2M0 middle low rectal cancer</brief_summary>
	<brief_title>Clinical Effect Neoadjuvant Hierarchical Treatment Based Chemotherapy</brief_title>
	<detailed_description>By set 3-Year disease-free survival ( DFS ) main objective , treatment strategy optimize neoadjuvant chemotherapy alone chemo-radio-chemo sequential treatment .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Inclusion criterion Pathologically confirm rectal adenocarcinoma . Distance &lt; 10cm end tumor anal verge find colonoscopy Tumor stage T34N02 ( pelvic MRI evaluation ) Patients without distant metastasis ( liver peritoneum , lung , aortic lymph node ) Patients Karnofsky score great â‰¥ 70 WBC &gt; 3.5 x 109/ml , PLT &gt; 10 x 109/ml , TBIL &lt; 22.2 umol/l , BUN &lt; 7.14mmol/l , Cr &lt; 132umol/l Ccr &gt; 50ml/min ( Evaluated use CockcroftGault formula : Creatinine clearance ( male ) = { ( 140 age ) x LBM ( kg ) } / { plasma creatinine ( mg/dl ) x 72 } ; Creatinine clearance ( female ) = 0.85 x { ( 140 age ) x LBM ( kg ) } / { plasma creatinine ( mg/dl ) x 72 } ) Patients must sign informed consent form Female subject must contraceptive trial Patients receive form chemotherapy radiotherapy No important relate disease ( tumor , severe heart disease central nervous system disease , etc . ) Age must equal 20 must equal less 70 Exclusion criterion Previously receive radiation therapy , chemotherapy antitumor biological therapy Previously receive immunosuppressive therapy Participation interventional clinical trial past time Suffering malignant colonic neoplasm simultaneously With peripheral neuropathy ( WHO I level ) Affected cognitive ability neurological psychiatric abnormality Including central nervous system metastasis Medical history severe allergy allergic constitution Severe pulmonary heart disease history Female patient pregnancy lactation refuse contraception Previously malignant tumor Exit criterion Occurrence bleeding , obstruction , perforation complication Occurrence distant metastasis period neoadjuvant therapy Adverse reaction , tolerate want continue receive treatment Patients voluntarily quit Capecitabinerelated Grade 4 HandFoot Syndrome</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Neoadjuvant Chemotherapy</keyword>
</DOC>